Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 164, Issue 1, Pages 68-82
Publisher
Wiley
Online
2011-03-30
DOI
10.1111/j.1476-5381.2011.01383.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peroxisome Proliferator-Activated Receptor γ and Lung Cancer Biology
- (2016) Jesse Roman JOURNAL OF INVESTIGATIVE MEDICINE
- Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
- (2015) Raju C. Reddy et al. NEOPLASIA
- Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors
- (2010) Fanny Lalloyer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
- (2010) Fariborz Rashid-Kolvear et al. BMC CANCER
- The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease
- (2010) Amir J Guri et al. BMC GASTROENTEROLOGY
- Peroxisome proliferator-activated receptor γ in bladder cancer: A promising therapeutic target
- (2010) Jose J Mansure et al. CANCER BIOLOGY & THERAPY
- Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone
- (2010) Jung Ok Ban et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials
- (2010) P. D. Home et al. DIABETOLOGIA
- Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro
- (2010) Jun Yu et al. HEPATOLOGY
- Cytotoxic Flavonoids as Agonists of Peroxisome Proliferator-Activated Receptor γ on Human Cervical and Prostate Cancer Cells
- (2010) Jee-Young Lee et al. JOURNAL OF NATURAL PRODUCTS
- SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescence
- (2010) Limin Han et al. NUCLEIC ACIDS RESEARCH
- The Effect of the PPAR-γ Agonist Rosiglitazone on Neuroblastoma SK-N-SH Cells in a Metastatic Xenograft Mouse Model
- (2010) Nina Krieger-Hinck et al. ONCOLOGY RESEARCH
- Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
- (2010) L. Peyrin-Biroulet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer Role of PPARγAgonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes
- (2010) P. J. Simpson-Haidaris et al. PPAR Research
- PPARs and Anticancer Therapies
- (2010) Michael E. C. Robbins et al. PPAR Research
- Therapeutic Implications of PPARγin Human Osteosarcoma
- (2010) Eric R. Wagner et al. PPAR Research
- Combined Low Doses of PPARγ and RXR Ligands Trigger an Intrinsic Apoptotic Pathway in Human Breast Cancer Cells
- (2009) Daniela Bonofiglio et al. AMERICAN JOURNAL OF PATHOLOGY
- Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells
- (2009) Shima Kumei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activating Peroxisome Proliferator-Activated Receptor Mutant Promotes Tumor Growth In vivo by Enhancing Angiogenesis
- (2009) L. Tian et al. CANCER RESEARCH
- Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
- (2009) John David Norris et al. CHEMISTRY & BIOLOGY
- Combination peroxisome proliferator-activated receptor γ and α agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content
- (2009) R. Balasubramanian et al. DIABETIC MEDICINE
- PPARγ and RXRγ ligands act synergistically as potent antineoplastic agentsin vitroandin vivoglioma models
- (2009) Alessio Papi et al. JOURNAL OF NEUROCHEMISTRY
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells
- (2009) Chan Woo Cheon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor γ involves angiogenesis inhibition
- (2009) Yu-Wei Dong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The Role of PPAR Receptors and Leukotriene Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer
- (2009) Thomas E. Adrian et al. PPAR Research
- Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γAgonists
- (2009) Martin B. Oleksiewicz et al. PPAR Research
- PPARs: A Double-Edged Sword in Cancer Therapy?
- (2009) Dipak Panigrahy et al. PPAR Research
- Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-γand Plasminogen Activator Inhibitor-1
- (2009) Jennifer C. Carter et al. PPAR Research
- Role of PPARs in Radiation-Induced Brain Injury
- (2009) Sriram Ramanan et al. PPAR Research
- PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-κB signals
- (2008) ShouWei Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Peroxisome Proliferator–Activated Receptor β/δ Expression and Activation in Lung Cancer
- (2008) Tetyana V. Pedchenko et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Activation of Peroxisome Proliferator–Activated Receptor β/δ Induces Lung Cancer Growth via Peroxisome Proliferator–Activated Receptor Coactivator γ-1α
- (2008) ShouWei Han et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease
- (2008) K. N. Prasad et al. ANNALS OF ONCOLOGY
- PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells
- (2008) W Chearwae et al. BRITISH JOURNAL OF CANCER
- Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator-Activated Receptor
- (2008) R. Nemenoff et al. Cancer Prevention Research
- Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer
- (2008) A. Mustafa et al. CLINICAL CANCER RESEARCH
- Overexpression of Jab1 in Hepatocellular Carcinoma and Its Inhibition by Peroxisome Proliferator-Activated Receptor Ligands In vitro and In vivo
- (2008) M.-C. Hsu et al. CLINICAL CANCER RESEARCH
- Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin
- (2008) G. D. Girnun et al. CLINICAL CANCER RESEARCH
- Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials
- (2008) M. Monami et al. DIABETES CARE
- Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: Association with differentiation, proliferation and clinical outcome
- (2008) E. Mylona et al. EJSO
- Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good Prognosis
- (2008) Shuji Ogino et al. GASTROENTEROLOGY
- Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers
- (2008) Ronald A. Lubet et al. INTERNATIONAL JOURNAL OF CANCER
- Peroxisome Proliferator-activated Receptor γ Down-regulates Follistatin in Intestinal Epithelial Cells through SP1
- (2008) Brian M. Necela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Troglitazone, a peroxisome proliferator-activated receptor γ ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells
- (2008) Yan-Ming Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- PPAR- Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
- (2008) Terry Lichtor et al. PPAR Research
- Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
- (2008) Tatiana M. Garcia-Bates et al. PPAR Research
- PPARs and RXRs in Male and Female Fertility and Reproduction
- (2008) P. Froment PPAR Research
- The Role of PPAR-γand Its Interaction with COX-2 in Pancreatic Cancer
- (2008) Guido Eibl PPAR Research
- The Role of PPAR in the Cyclooxygenase Pathway in Lung Cancer
- (2008) Saswati Hazra et al. PPAR Research
- The Role of PPAR in Hepatocellular Carcinoma
- (2008) Ivan Borbath et al. PPAR Research
- Synergistic Effects of PPARγLigands and Retinoids in Cancer Treatment
- (2008) Masahito Shimizu et al. PPAR Research
- PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
- (2007) Frank J. Gonzalez et al. TOXICOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started